Patents by Inventor Venkat R. Goskonda

Venkat R. Goskonda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL CANNABINOID FORMULATIONS
    Publication number: 20160228405
    Abstract: Oral cannabinoid formulations, including an aqueous-based oral dronabinol solution, that are stable at room or refrigerated temperatures and may possess improved in vivo absorption profiles with faster onset and lower inter-subject variability.
    Type: Application
    Filed: April 19, 2016
    Publication date: August 11, 2016
    Inventors: Venkat R. Goskonda, Ashok Chavan, Amit Kokate, Howard Gill
  • SUBLINGUAL NALOXONE SPRAY
    Publication number: 20160199294
    Abstract: The invention provides storage stable sublingual formulations containing naloxone, a pharmaceutically acceptable salt or a derivative thereof. The invention further provides methods for treating opioid dependence, opioid overdose, and congenital insensitivity to pain with anhidrosis by administering the sublingual formulations of the present invention to a patient in need thereof.
    Type: Application
    Filed: March 21, 2016
    Publication date: July 14, 2016
    Inventors: Kiran Amancha, Shivani Chilampalli, Thrimoorthy Potta, Ning Shan, Ningxin Yan, Onkar N. Singh, Venkat R. Goskonda
  • SUBLINGUAL FENTANYL SPRAY
    Publication number: 20160193142
    Abstract: The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
    Type: Application
    Filed: February 12, 2016
    Publication date: July 7, 2016
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Linet Kattookaran, Neha Parikh
  • Oral cannabinoid formulations
    Patent number: 9345771
    Abstract: Oral cannabinoid formulations, including an aqueous-based oral dronabinol solution, that are stable at room or refrigerated temperatures and may possess improved in vivo absorption profiles with faster onset and lower inter-subject variability.
    Type: Grant
    Filed: October 4, 2012
    Date of Patent: May 24, 2016
    Assignee: INSYS DEVELOPMENT COMPANY, INC.
    Inventors: Venkat R. Goskonda, Ashok Chavan, Amit Kokate, Howard Gill
  • SUBLINGUAL FENTANYL SPRAY
    Publication number: 20160095846
    Abstract: The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable sale thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
    Type: Application
    Filed: December 11, 2015
    Publication date: April 7, 2016
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Linet Kattookaran, Neha Parikh
  • Method of treating pain by administering sublingual fentanyl spray
    Patent number: 9289387
    Abstract: The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
    Type: Grant
    Filed: July 31, 2014
    Date of Patent: March 22, 2016
    Assignee: INSYS DEVELOPMENT COMPANY, INC.
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Linet Kattookaran, Neha Parikh
  • SUBLINGUAL BUPRENORPHINE SPRAY
    Publication number: 20160045430
    Abstract: The invention provides sublingual formulations containing buprenorphine, a pharmaceutically acceptable salt thereof, or a derivative thereof. The invention further provides sublingual formulations containing buprenorphine and naloxone, pharmaceutically acceptable salts thereof or derivatives thereof.
    Type: Application
    Filed: October 27, 2015
    Publication date: February 18, 2016
    Inventors: Kiran P. Amancha, Chandeshwari S. Chilampalli, Venkat R. Goskonda
  • Sublingual fentanyl spray
    Patent number: 9241935
    Abstract: The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable sale thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
    Type: Grant
    Filed: July 31, 2014
    Date of Patent: January 26, 2016
    Assignee: Insys Pharma, Inc.
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Linet Kattookaran, Neha Parikh
  • SUBLINGUAL NALOXONE SPRAY
    Publication number: 20160008349
    Abstract: The invention provides storage stable sublingual formulations containing naloxone, a pharmaceutically acceptable salt or a derivative thereof. The invention further provides methods for treating opioid dependence, opioid overdose, and congenital insensitivity to pain with anhidrosis by administering the sublingual formulations of the present invention to a patient in need thereof.
    Type: Application
    Filed: June 4, 2015
    Publication date: January 14, 2016
    Inventors: Kiran Amancha, Shivani Chilampalli, Thrimoorthy Potta, Ningxin Yan, Venkat R. Goskonda
  • DICLOFENAC SUBLINGUAL SPRAY
    Publication number: 20160008306
    Abstract: The present invention is directed to diclofenac sublingual spray formulations. The present invention is also directed to methods for treating pain and inflammation by administering the formulations of the present invention to patients in need thereof.
    Type: Application
    Filed: July 6, 2015
    Publication date: January 14, 2016
    Inventors: Kiran Kumar Vangara, Daniela Bockenstedt, Ningxin Yan, Rajesh Pandya, Venkat R. Goskonda
  • Sublingual buprenorphine spray
    Patent number: 9216175
    Abstract: The invention provides sublingual formulations containing buprenorphine, a pharmaceutically acceptable salt thereof, or a derivative thereof. The invention further provides sublingual formulations containing buprenorphine and naloxone, pharmaceutically acceptable salts thereof or derivatives thereof. The invention further provides a method of treating pain or opioid dependence by administering sublingual formulations containing buprenorphine, a pharmaceutically acceptable salt thereof, or a derivative thereof to a patient in need thereof.
    Type: Grant
    Filed: August 26, 2014
    Date of Patent: December 22, 2015
    Assignee: Insys Pharma, Inc.
    Inventors: Kiran P. Amancha, Chandeshwari S. Chilampalli, Venkat R. Goskonda
  • STABLE CANNABINOID FORMULATIONS
    Publication number: 20150342902
    Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.
    Type: Application
    Filed: July 31, 2015
    Publication date: December 3, 2015
    Inventors: Kiran Kumar Vangara, Huaguang Li, Ningxin Yan, Hung Q. Nguyen, Venkat R. Goskonda
  • STABLE CANNABINOID FORMULATIONS
    Publication number: 20150343071
    Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.
    Type: Application
    Filed: May 28, 2015
    Publication date: December 3, 2015
    Inventors: Kiran Kumar Vangara, Huaguang Li, Ningxin Yan, Hung Q. Nguyen, Venkat R. Goskonda
  • ONDANSETRON SUBLINGUAL SPRAY FORMULATION
    Publication number: 20150133517
    Abstract: The invention is directed to sublingual spray formulations containing ondansetron or a pharmaceutically acceptable salt thereof and water. The invention is further directed to methods for treating or preventing nausea and emesis associated with cancer treatments by administering sublingual spray formulations containing ondansetron or a pharmaceutically acceptable salt thereof to a patient in need thereof.
    Type: Application
    Filed: November 14, 2014
    Publication date: May 14, 2015
    Inventors: Kiran Kumar Vangara, Chandeshwari Shivani Chilampalli, Venkat R. Goskonda
  • SUBLINGUAL BUPRENORPHINE SPRAY
    Publication number: 20150071971
    Abstract: The invention provides sublingual formulations containing buprenorphine, a pharmaceutically acceptable salt thereof, or a derivative thereof. The invention further provides sublingual formulations containing buprenorphine and naloxone, pharmaceutically acceptable salts thereof or derivatives thereof. The invention further provides a method of treating pain or opioid dependence by administering sublingual formulations containing buprenorphine, a pharmaceutically acceptable salt thereof, or a derivative thereof to a patient in need thereof.
    Type: Application
    Filed: August 26, 2014
    Publication date: March 12, 2015
    Inventors: Kiran P. Amancha, Chandeshwari S. Chilampalli, Venkat R. Goskonda
  • SUBLINGUAL FENTANYL SPRAY
    Publication number: 20140343100
    Abstract: The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
    Type: Application
    Filed: July 31, 2014
    Publication date: November 20, 2014
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Linet Kattookaran, Neha Parikh
  • SUBLINGUAL FENTANYL SPRAY
    Publication number: 20140343288
    Abstract: The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable sale thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
    Type: Application
    Filed: July 31, 2014
    Publication date: November 20, 2014
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Linet Kattookaran, Neha Parikh
  • Sublingual fentanyl spray
    Patent number: 8835459
    Abstract: The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable sale thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
    Type: Grant
    Filed: May 15, 2013
    Date of Patent: September 16, 2014
    Assignee: Insys Therapeutics, Inc.
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Linet Kattookaran, Neha Parikh
  • Sublingual fentanyl spray and methods of treating pain
    Patent number: 8835460
    Abstract: The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
    Type: Grant
    Filed: May 15, 2013
    Date of Patent: September 16, 2014
    Assignee: Insys Therapeutics, Inc.
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Linet Kattookaran, Neha Parikh
  • ORAL CANNABINOID FORMULATIONS
    Publication number: 20140100269
    Abstract: Oral cannabinoid formulations, including an aqueous-based oral dronabinol solution, that are stable at room or refrigerated temperatures and may possess improved in vivo absorption profiles with faster onset and lower inter-subject variability.
    Type: Application
    Filed: October 4, 2012
    Publication date: April 10, 2014
    Applicant: INSYS THERAPEUTICS, INC.
    Inventors: Venkat R. Goskonda, Ashok Chavan, Amit Kokate, Howard Gill